Although RB1 inactivation is highly characteristic of SCLC (> 90%) (George et al., 2015), targeted next‐generation sequencing (OncoPanel) analyses revealed no RB1 mutation in either DFCI168 or SW1271. The gene discussed is RB1; the disease is small cell lung carcinoma.